Advances in present understanding of pathophysiologic mechanisms in inflammatory bowel disease (IBD) have been enhanced enormously through genetic approaches. IBD genetics advances have been catalyzed through large collaborative efforts, notably the NIDDK IBD Genetics Consortium (NIDDK IBDGC), comprised of a central data coordinating center (DCC) and six genetics research centers (GRCs). We present preliminary data from the Immunochip project, a large international collaborative effort, which has identified 163 loci associated to IBD. Data management for Immunochip project has been managed by the NIDDK IBDGC DCC. Importantly, the identification of such a large number of new loci increases the power to integrate complementary datasets to develop predictive models that will deepen our understanding of altered biologic pathways underlying IBD susceptibility. This proposal outlines progress gene identification and network analyses. This knowledge will be critical in more accurately prioritizin which pathways to target for the development of new therapies.
In Specific Aim 1, we propose to generate high quality IBD association datasets that are the foundation of a deeper understanding of disease pathogenesis. Integration of extremely large genome-wide association studies (GWAS), Immunochip data, and upcoming custom IBD exome chip data will be undertaken. Comparative studies in non-European ancestry IBD cohorts, including African-American and Puerto Rican IBD using both genome-wide and targeted approaches are proposed. Fine-mapping and annotation will refine the molecular basis for association signals.
In Specific Aim 2, we provide a framework for integration genetic association data with complementary datasets in order to develop increasingly improved predictive models. Priorities for biospecimens collections and major new "-omics" based studies are proposed.
In Specific Aim 3, we propose to enhance and expand DCC capabilities to accommodate the accelerating pace of discovery. The DCC has played an essential in successfully managing a marked increase of responsibilities and pace of discovery. This project is highly innovative due to the scope of the project and data generated, the novel integration of complementary data and cross-disciplinary, cross-institutional and cross-consortial collaborative and training efforts.

Public Health Relevance

The goal of the NIDDK Inflammatory Bowel Disease Genetics Consortium is to advance genetic and clinical understanding of Crohn's disease and Ulcerative Colitis. The Data Coordinating Center (DCC) will facilitate scientific interaction between the genetic centers that make up the Consortium and with the scientific community, through the collection, organization and analysis of research data. The DCC plays a key role in the planning, development and implementation of the studies and objectives of the Consortium.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project--Cooperative Agreements (U01)
Project #
3U01DK062429-15S1
Application #
8924258
Study Section
Special Emphasis Panel (ZDK1-GRB-7 (O4))
Program Officer
Karp, Robert W
Project Start
2002-09-30
Project End
2017-08-31
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
15
Fiscal Year
2014
Total Cost
$84,236
Indirect Cost
$34,539
Name
Icahn School of Medicine at Mount Sinai
Department
Genetics
Type
Schools of Medicine
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
Carmi, Shai; Hui, Ken Y; Kochav, Ethan et al. (2014) Sequencing an Ashkenazi reference panel supports population-targeted personal genomics and illuminates Jewish and European origins. Nat Commun 5:4835
Hou, Lin; Chen, Min; Zhang, Clarence K et al. (2014) Guilt by rewiring: gene prioritization through network rewiring in genome wide association studies. Hum Mol Genet 23:2780-90
Hedl, Matija; Lahiri, Amit; Ning, Kaida et al. (2014) Pattern recognition receptor signaling in human dendritic cells is enhanced by ICOS ligand and modulated by the Crohn's disease ICOSLG risk allele. Immunity 40:734-46
Ferguson, John P; Cho, Judy H; Yang, Can et al. (2013) Empirical Bayes correction for the Winner's Curse in genetic association studies. Genet Epidemiol 37:60-8
Gathungu, Grace; Kim, Mi-Ok; Ferguson, John P et al. (2013) Granulocyte-macrophage colony-stimulating factor autoantibodies: a marker of aggressive Crohn's disease. Inflamm Bowel Dis 19:1671-80
Zhang, W; Hui, K Y; Gusev, A et al. (2013) Extended haplotype association study in Crohn's disease identifies a novel, Ashkenazi Jewish-specific missense mutation in the NF-*B pathway gene, HEATR3. Genes Immun 14:310-6
Lazarev, Mark; Huang, Chengrui; Bitton, Alain et al. (2013) Relationship between proximal Crohn's disease location and disease behavior and surgery: a cross-sectional study of the IBD Genetics Consortium. Am J Gastroenterol 108:106-12
Beaudoin, Mélissa; Goyette, Philippe; Boucher, Gabrielle et al. (2013) Deep resequencing of GWAS loci identifies rare variants in CARD9, IL23R and RNF186 that are associated with ulcerative colitis. PLoS Genet 9:e1003723
Kabakchiev, Boyko; Silverberg, Mark S (2013) Expression quantitative trait loci analysis identifies associations between genotype and gene expression in human intestine. Gastroenterology 144:1488-96, 1496.e1-3
Kenny, Eimear E; Pe'er, Itsik; Karban, Amir et al. (2012) A genome-wide scan of Ashkenazi Jewish Crohn's disease suggests novel susceptibility loci. PLoS Genet 8:e1002559

Showing the most recent 10 out of 37 publications